Acinetobacter baumannii represents a formidable nosocomial pathogen, largely due to its rapid acquisition of multidrug resistance and its capacity to cause severe infections. This Gram‐negative ...

Antibiotic treatments are losing effectiveness against a range of common bacterial pathogens, including E. coli, K.

Antimicrobial resistance (AMR) in clinically relevant bacterial pathogens represents a major and growing challenge to ...

Australian researchers have developed a powerful new way to target deadly, drug-resistant bacteria by designing antibodies that recognize a sugar found only on bacterial cells—an advance that could ...